3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
6
Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
2
Small Cell Lung Carcinoma
2
Neoplasm Metastasis
2
Lung Neoplasms
2
Head and Neck Neoplasms
2
Non-Muscle Invasive Bladder Neoplasms
1
Myeloproliferative Disorders
1
Leukemia, Myeloid, Acute
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Laryngeal Diseases
1
Infections
1
Hematologic Neoplasms
1
Esophageal Squamous Cell Carcinoma
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
COVID-19
1
Breast Neoplasms
1
Anemia, Refractory, with Excess of Blasts
1
Adenocarcinoma Of Esophagus
1
Interventions
Standard of Care
8
Hydroxychloroquine
4
BNT162 Vaccine
4
Practice Guidelines as Topic
3
Blood Specimen Collection
3
2019-nCoV Vaccine mRNA-1273
3
tocilizumab
2
sotrovimab
2
cilgavimab and tixagevimab drug combination
2
Specimen Handling
2
Sodium Chloride
2
CVnCoV COVID-19 vaccine
2
COVID-19 Vaccines
2
COH04S1 COVID-19 vaccine
2
Azithromycin
2
sinovac COVID-19 vaccine
1
selinexor
1
remdesivir
1
proxalutamide
1
palbociclib
1
ogalvibart
1
monalizumab
1
lenzilumab
1
crexavibart
1
ciclesonide
1
bemcentinib
1
avdoralimab
1
acalabrutinib
1
XAV-19
1
Therapeutics
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
COVID-19
×
monalizumab
×
Clear all
NCT04333914
2022-09-30
IMMUNONCOVID
Centre Leon Berard
Phase 2
Completed
19 enrolled